S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SYRS Syros Pharmaceuticals Inc

0.0925

-0.0435 (-31.99%)

Last Updated: 11:41:43

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Syros Pharmaceuticals Charts.

Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Syros Pharmaceuticals Charts.

Syros Pharmaceuticals Inc News

Form EFFECT - Notice of Effectiveness
Tuesday 11 March 2025 (13 hours ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Monday 10 March 2025 (2 days ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Monday 10 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Monday 10 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 March 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 28 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration
Friday 28 February 2025 (2 weeks ago) • Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 16 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 30 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 27 December 2024 (2 months ago) • Edgar (US Regulatory)

More Syros Pharmaceuticals Inc News Articles

Leonteq Securities

Societe Generale Effekten

Bank of Montreal Capped ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions